Literature DB >> 31394114

Insulin/IGF signaling and discoidin domain receptors: An emerging functional connection.

Veronica Vella1, Roberta Malaguarnera2, Maria Luisa Nicolosi1, Andrea Morrione3, Antonino Belfiore4.   

Abstract

The insulin/insulin-like growth factor system (IIGFs) plays a fundamental role in the regulation of prenatal and postnatal growth, metabolism and homeostasis. As a consequence, dysregulation of this axis is associated with growth disturbance, type 2 diabetes, chronic inflammation and tumor progression. A functional crosstalk between IIGFs and discoidin domain receptors (DDRs) has been recently discovered. DDRs are non-integrin collagen receptors that canonically undergo slow and long-lasting autophosphorylation after binding to fibrillar collagen. While both DDR1 and DDR2 functionally interact with IIGFs, the crosstalk with DDR1 is so far better characterized. Notably, the IIGFs-DDR1 crosstalk presents a feed-forward mechanism, which does not require collagen binding, thus identifying novel non-canonical action of DDR1. Further studies are needed to fully explore the role of this IIGFs-DDRs functional loop as potential target in the treatment of inflammatory and neoplastic disorders.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Breast cancer; DDR1; DDR2; Discoidin domain receptors; Insulin receptor; Insulin-like growth factor system; Insulin-like growth factor-2; Isoform A; Thyroid cancer

Mesh:

Substances:

Year:  2019        PMID: 31394114     DOI: 10.1016/j.bbamcr.2019.118522

Source DB:  PubMed          Journal:  Biochim Biophys Acta Mol Cell Res        ISSN: 0167-4889            Impact factor:   4.739


  13 in total

1.  Targeting adipocytic discoidin domain receptor 2 impedes fat gain while increasing bone mass.

Authors:  Xiaoyu Yang; Jing Li; Liting Zhao; Yazhuo Chen; Zhijun Cui; Taotao Xu; Xu Li; Shufang Wu; Yan Zhang
Journal:  Cell Death Differ       Date:  2021-10-13       Impact factor: 12.067

Review 2.  New Insights from IGF-IR Stimulating Activity Analyses: Pathological Considerations.

Authors:  Joseph A M J L Janssen
Journal:  Cells       Date:  2020-04-02       Impact factor: 6.600

Review 3.  Insulin-like growth factor receptor signaling in tumorigenesis and drug resistance: a challenge for cancer therapy.

Authors:  Hui Hua; Qingbin Kong; Jie Yin; Jin Zhang; Yangfu Jiang
Journal:  J Hematol Oncol       Date:  2020-06-03       Impact factor: 17.388

Review 4.  Communication in the Cancer Microenvironment as a Target for Therapeutic Interventions.

Authors:  Agnieszka Dominiak; Beata Chełstowska; Wioletta Olejarz; Grażyna Nowicka
Journal:  Cancers (Basel)       Date:  2020-05-14       Impact factor: 6.639

Review 5.  Novel Regulators of the IGF System in Cancer.

Authors:  Caterina Mancarella; Andrea Morrione; Katia Scotlandi
Journal:  Biomolecules       Date:  2021-02-12

6.  A human-based multi-gene signature enables quantitative drug repurposing for metabolic disease.

Authors:  James A Timmons; Andrew Anighoro; Robert J Brogan; Jack Stahl; Claes Wahlestedt; David Gordon Farquhar; Jake Taylor-King; Claude-Henry Volmar; William E Kraus; Stuart M Phillips
Journal:  Elife       Date:  2022-01-17       Impact factor: 8.713

7.  Cabozantinib Is Effective in Melanoma Brain Metastasis Cell Lines and Affects Key Signaling Pathways.

Authors:  Trond Are Mannsåker; Tuyen Hoang; Synnøve Nymark Aasen; Ole Vidhammer Bjørnstad; Himalaya Parajuli; Terje Sundstrøm; Frits Alan Thorsen
Journal:  Int J Mol Sci       Date:  2021-11-14       Impact factor: 5.923

8.  Novel Mechanisms of Tumor Promotion by the Insulin Receptor Isoform A in Triple-Negative Breast Cancer Cells.

Authors:  Veronica Vella; Marika Giuliano; Alessandro La Ferlita; Michele Pellegrino; Germano Gaudenzi; Salvatore Alaimo; Michele Massimino; Alfredo Pulvirenti; Alessandra Dicitore; Paolo Vigneri; Giovanni Vitale; Roberta Malaguarnera; Andrea Morrione; Andrew H Sims; Alfredo Ferro; Marcello Maggiolini; Rosamaria Lappano; Ernestina Marianna De Francesco; Antonino Belfiore
Journal:  Cells       Date:  2021-11-12       Impact factor: 6.600

Review 9.  CAM-DR: Mechanisms, Roles and Clinical Application in Tumors.

Authors:  Yuejiao Huang; Yuchan Wang; Jie Tang; Shiyi Qin; Xianjuan Shen; Song He; Shaoqing Ju
Journal:  Front Cell Dev Biol       Date:  2021-07-06

10.  DDR1 Affects Metabolic Reprogramming in Breast Cancer Cells by Cross-Talking to the Insulin/IGF System.

Authors:  Veronica Vella; Marika Giuliano; Maria Luisa Nicolosi; Maria Giovanna Majorana; Małgorzata Anna Marć; Maria Grazia Muoio; Andrea Morrione; Marcello Maggiolini; Rosamaria Lappano; Ernestina Marianna De Francesco; Antonino Belfiore
Journal:  Biomolecules       Date:  2021-06-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.